Moderna Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 67 trades in Moderna Inc (NASDAQ: MRNA) since 2020, across 6 members, worth an estimated $933.03K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 35 buys against 32 sells, a modestly buy-led skew, with Democratic members responsible for 97% of the trades and Republican members 3%. The most recent disclosure shown was filed July 2026, and Rohit Khanna has filed the most MRNA transactions among those shown, with 6. One notable disclosed move was a purchase by Rohit Khanna on January 29, 2026, up 238.9% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Moderna Inc's current Quantellect Tide Score is 85 out of 100 (Storm Surge), Top 5% of universe (3876); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Moderna Inc (MRNA) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Moderna congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
 Rohit Khanna House | Jul 6, 2026 | Jun 30, 2026 | 6 days | BUY |  $1,001 - $15,000 | +126.80% | Spouse | |
Rohit Khanna House | Jun 9, 2026 | May 15, 2026 | 25 days | SELL | $1,001 - $15,000 | +223.88% | Spouse | |
Rohit Khanna House | Jun 9, 2026 | May 1, 2026 | 39 days | SELL | $1,001 - $15,000 | +250.08% | Child | |
Rohit Khanna House | May 11, 2026 | Apr 13, 2026 | 28 days | BUY | $1,001 - $15,000 | +213.40% | Spouse | |
Rohit Khanna House | Feb 6, 2026 | Jan 29, 2026 | 8 days | BUY | $1,001 - $15,000 | +238.95% | Spouse | |
Rohit Khanna House | Feb 6, 2026 | Jan 23, 2026 | 14 days | BUY | $1,001 - $15,000 | +226.07% | Child |
Moderna (MRNA) congressional trading FAQ
Can members of Congress legally trade Moderna (MRNA) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Moderna (MRNA), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional Moderna (MRNA) trades public?
Yes. Every congressional trade in Moderna (MRNA) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Moderna (MRNA)?
Members of Congress have disclosed 67 trades in Moderna (MRNA) worth $933.03K across 6 members, according to public STOCK Act filings.
Which members of Congress have traded Moderna (MRNA)?
Recent and active filers of Moderna (MRNA) disclosures include Rohit Khanna. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Moderna (MRNA) more?
Across disclosed Moderna (MRNA) trades, 97% were by Democrats and 3% by Republicans, led by Democrats (97%).
What is the most recent congressional Moderna (MRNA) trade?
The most recent disclosed Moderna (MRNA) trade was a purchase by Rohit Khanna, filed Jul 5, 2026.
What is Moderna (MRNA)'s Tide Score?
Moderna (MRNA) has a Quantellect Tide Score of 85 (Storm Surge). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.
Browse all stocks Congress tradesCongressional trading overviewModerna (MRNA) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.